A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
Genotoxic drugs constitute a major treatment modality for human cancers; however, cancer cells' intrinsic DNA repair capability often increases the threshold of lethality and renders these drugs ineffective. The emerging roles of HDACs in DNA repair provide new opportunities for improving tradi...
Main Authors: | Hemann, Michael, Liu, Chuan, Ding, Hongyu, Li, Xiaoxi, Pallasch, Christian, Hong, Liya, Guo, Dianwu, Chen, Yi, Wang, Difei, Wang, Wei, Wang, Yajie, Jiang, Hai, 1979- |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Wiley Blackwell
2015
|
Online Access: | http://hdl.handle.net/1721.1/97593 |
Similar Items
-
The Advent of “CyWar” : Are We Ready?
by: Kumar Ramakrishna
Published: (2019) -
Design and synthesis of sulfur-containing butylated hydroxytoluene: antioxidant potency and selective anticancer agent
by: Ahmad, Mohd H., et al.
Published: (2019) -
Identification of Nonradiative Decay Pathways in Cy3
by: Hart, Stephanie M., et al.
Published: (2021) -
A Developmental Switch in Microglial HDAC Function
by: Mathys, Hansruedi, et al.
Published: (2019) -
Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
by: Lee, T. I., et al.
Published: (2020)